Director of Business Development

WHY NOETIK

NOETIK is a frontier therapeutics company harnessing AI to deeply understand human biology and redefine clinical outcomes in oncology. Leveraging the largest proprietary multimodal oncology dataset of its kind, uniquely integrating deep spatial profiling with routine clinical assays, NOETIK’s foundation AI models precisely match therapeutic targets to patient subpopulations and accurately predict clinical efficacy. This AI-first approach elevates therapeutic development from probabilistic guesswork to precision science.

The Opportunity  

Noetik is hiring a Director of Business Development to build and own the top of the commercial funnel. This is a new-revenue role: you will develop pipeline strategy for Noetik’s AI oncology models, scout and qualify partnership opportunities globally, and carry relationships from a first informal conversation through to structured, executable deals with pharma and biotech.  

You will join at the inflection point immediately following an anchor partnership — with a proven deal template, credible external validation, and a mandate to replicate and diversify it. The Director will be the systematic engine behind that expansion: finding the right counterparties, engaging the right people inside them, and making sure every conversation moves toward a defined next step.  

What  You’ll  Own  

New revenue streams and pipeline strategy  

Develop and execute the commercial pipeline strategy for Noetik’s AI oncology platform, including model licensing, subscription frameworks, bespoke dataset generation, co-development, and biomarker and translational collaborations.  

Identify and build the case for new revenue streams beyond the current partnership model — new indications, new buyer profiles, and new commercial constructs.  

Build and maintain the target account map: which pharma and biotech organizations need Noetik’s models, why, when, and through which internal sponsor.  

Search, evaluation, and top-of-funnel generation  

Own top-of-funnel generation  for asset in-licensing  end to end: source, scout, and assess partnership opportunities globally across large pharma, mid-cap biopharma, and clinical-stage biotech.  

Evaluate and prioritize opportunities against pipeline fit, indication relevance, data needs, deal size, and probability of execution — bringing a clear, defensible point of view on where Noetik should spend its  resources time .  

Maintain a systematic, strategic approach to coverage rather than opportunistic outreach: segmented targeting, deliberate sequencing, and disciplined qualification criteria.  

Selling to pharma and biotech  

Articulate Noetik’s science and platform value proposition credibly to both scientific and commercial audiences — from discovery and translational research leaders to AI and data science, oncology R&D, and business development counterparts.  

Translate complex model capabilities into concrete partner problems solved: target discovery, patient stratification, response prediction, indication selection, and clinical asset positioning.  

Support deal shaping and structuring in partnership with the Chief Business Officer and leadership, including commercial framing, term development, and negotiation preparation.  

Lead tracking, follow-up, and meeting readiness  

Track leads, contacts, conversation history, and deal detail rigorously — maintaining an accurate, current, and trustworthy view of pipeline health and stage progression.  

Drive appropriate follow-up, clear next steps, and forward planning on every open thread; nothing goes cold for lack of discipline.  

Ensure Noetik is having the right conversations with the right people, and that internal teams are fully prepared for every meeting — briefing documents, stakeholder profiles, objectives, and anticipated objections.  

Stakeholder management, internal and external  

Serve as the connective tissue between external partners and …